FDA Inspection 1179291 — Biovet AD
The FDA completed an inspection of Biovet AD on Aug 12, 2022 in Peshtera. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 12, 2022
- Fiscal Year
- 2022
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Peshtera (Bulgaria)